Showing results (171-180 of 250) with videos related to
Sort By:
Pageof 25
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1994
Phase II trial of edatrexate in patients with advanced hepatocellular carcinomaR Pazdur, D F Moore, B Bready, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1990
Phase II study of fluorouracil and recombinant interferon alfa-2a in previously untreated advanced colorectal carcinomaR Pazdur, J A Ajani, Y Z Patt, et al.Anti-Cancer Drugs|July 8, 2000
Phase II trial of 5-fluorouracil, folinic acid and recombinant alpha-2a-interferon in patients with advanced colorectal cancerF Ravandi, M E Rytting, C Osmon, et al.Cancer|February 15, 1990
Comparison of etoposide and cisplatin with bis-chloro-ethylnitrosourea, thiotepa, vincristine, and cyclophosphamide for salvage treatment in small cell lung cancer. A Southwest Oncology Group StudyR M O'Bryan, J J Crowley, P N Kim, et al.Cancer|November 1, 1993
Low serum alpha-fetoprotein level in patients with hepatocellular carcinoma as a predictor of response to 5-FU and interferon-alpha-2bY Z Patt, B Yoffe, C Charnsangavej, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1992
Clinical pharmacology of combined oral uracil and ftorafurD H Ho, W P Covington, R Pazdur, et al.Medical and Pediatric Oncology|January 1, 1978
Mitomycin-C alone and in combination with infused 5-fluorouracil to the treatment of disseminated gastrointestinal carcinomasT R Buroker, P N Kim, L H Baker, et al.Cancer Treatment Reports|September 1, 1979
Phase II evaluation of cis-dichlorodiammineplatinum(II) in advanced malignancies of the genitourinary and gynecologic organs: a Southwest Oncology Group StudyA H Rossof, R W Talley, R Stephens, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2017
Exploratory analysis of the association of depth of response and survival in patients with metastatic non-small-cell lung cancer treated with a targeted therapy or immunotherapyC E McCoach, G M Blumenthal, L Zhang, et al.Investigational New Drugs|November 1, 1991
Phase II study of intravenous 6-thioguanine in patients with advanced carcinoma of the pancreasJ A Ajani, R Pazdur, R J Winn, et al.Pageof 25